Filing search / Terns Pharmaceuticals, Inc. / "Cybersecurity"

8-K

EX-1.1

TERN Terns Pharmaceuticals, Inc.

12 Sep 24

Terns Announces Pricing of Upsized $150.15 Million Public Offering

6:01am

) Cybersecurity; Data Protection. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (i

8-K

EX-1.1

TERN Terns Pharmaceuticals, Inc.

15 May 23

Entry into a Material Definitive Agreement

4:44pm

similar coverage at reasonable cost from similar insurers as may be necessary to continue its business. (gg) Cybersecurity; Data Protection. Except

8-K

EX-1.1

tvl2ki28tz76qd04j6

23 Dec 22

Terns Announces Pricing of $75 Million Public Offering

4:10pm

8-K

EX-1.1

wzyvhzzt

16 Aug 22

Terns Announces $65 Million Oversubscribed Offering

5:18pm

DEF 14A

258n6tu6

29 Apr 22

Definitive proxy

4:22pm

S-3

EX-1.2

do9lj1 xjjk

8 Mar 22

Shelf registration

4:34pm

10-K

rx62yk 8y54t

30 Mar 21

Annual report

5:21pm

424B4

ipm69unm6 4oz63c

8 Feb 21

Prospectus supplement with pricing info

4:01pm

S-1/A

2ea1mxz

1 Feb 21

IPO registration (amended)

7:05am

S-1/A

EX-1.1

d19qlmoe tdjm088g

1 Feb 21

IPO registration (amended)

7:05am

S-1

EX-10.1

9xh25ucm

15 Jan 21

IPO registration

5:22pm

S-1

fll9u nys7q

15 Jan 21

IPO registration

5:22pm

DRS/A

du0p2wmnvo

16 Dec 20

Draft registration statement (amended)

12:00am

DRS

bdyu22xo6esovuai9wi6

10 Nov 20

Draft registration statement

12:00am